Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER? -- Ignore unavailable to you. Want to Upgrade?

To: Techno who wrote (27)	3/24/1999 1:14:00 PM
From: Robert Dydo	Respond to of 164

I would assume a year from now SynsorbPk has a strong chance to have FDA approval.

To: Techno who wrote (27)	3/24/1999 1:55:00 PM
From: John Trudeau	Read Replies (2) \| Respond to of 164

Techno, I think the market is being the judge here... and, judging from the market, it's gonna be 2 years. The IR person I spoke with said they have to re-work/modify the phase III trial format (I don't remember the exact words, but this was the jist of it). This would be done in the next 6 months, the trials will then continue, and after that, assuming the results are good, application to the FDA would be made. They are trying to line up their ducks so that this anticipated application proceeds quickly. The IR person said that analysts had lowered their earnings forecasts. This, combined with the prospect of more stock out there (and considerable debt), well.... like I said, a little too much risk with this kind of time line. Another thing, no mention from the IR person about Oncolytics.... until I brought it up (near the end of our conversation). Not a big deal, but a little more promotion wouldn't hurt. JT